Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Mantle Cell Lymphoma - Pipeline Review, H1 2015

 



(PharmaNewsWire.Com, June 24, 2017 ) This report provides comprehensive information on the therapeutic development for Mantle Cell Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Mantle Cell Lymphoma and special features on late-stage and discontinued projects.



Publisher's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Publisher's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.



The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.





For more information about this report at http://www.reportsweb.com/mantle-cell-lymphoma-pipeline-review-h1-2015



Report Scope



- The report provides a snapshot of the global therapeutic landscape of Mantle Cell Lymphoma

- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in the therapeutics development for Mantle Cell Lymphoma and enlists all their major and minor projects

- The report summarizes all the dormant and discontinued pipeline projects

- A review of the Mantle Cell Lymphoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- A detailed assessment of monotherapy and combination therapy pipeline projects

- Coverage of the Mantle Cell Lymphoma pipeline on the basis of target, MoA, route of administration and molecule type

- Latest news and deals relating related to pipeline products





Request a sample copy at http://www.reportsweb.com/inquiry&RW0001172452/sample



Reasons to buy



- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop strategic initiatives by understanding the focus areas of leading companies

- Identify and understand important and diverse types of therapeutics under development for Mantle Cell Lymphoma

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Devise corrective measures for pipeline projects by understanding Mantle Cell Lymphoma pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline





Key Company profiles



AbbVie Inc.

Accentia Biopharmaceuticals, Inc.

Actinium Pharmaceuticals, Inc.

Advancell

Affimed Therapeutics AG

Amgen Inc.

Astellas Pharma Inc.

Astex Pharmaceuticals, Inc.

Bayer AG

Bristol-Myers Squibb Company

Celgene Corporation

Celldex Therapeutics, Inc.

Eisai Co., Ltd.

Eli Lilly and Company

EpiZyme, Inc.

Gilead Sciences, Inc.

GlaxoSmithKline plc

ImmunoGen, Inc.

Incyte Corporation

Infinity Pharmaceuticals, Inc.

Johnson & Johnson

Karyopharm Therapeutics, Inc.

Kite Pharma, Inc.

MedImmune, LLC

Merck & Co., Inc.

Millennium Pharmaceuticals, Inc.

MorphoSys AG

Nordic Nanovector AS

Novartis AG

Onconova Therapeutics, Inc.

Onyx Pharmaceuticals, Inc.

Pfizer Inc.

Pharmacyclics, Inc.

Portola Pharmaceuticals, Inc.

Seattle Genetics, Inc.

Sevion Therapeutics, Inc.

Stemline Therapeutics, Inc.

Teva Pharmaceutical Industries Limited

TG Therapeutics, Inc.





Ask for Discount at http://www.reportsweb.com/inquiry&RW0001172452/discount





List of Tables



Number of Products under Development for Mantle Cell Lymphoma, H1 2015 15

Number of Products under Development for Mantle Cell Lymphoma-Comparative Analysis, H1 2015 16

Number of Products under Development by Companies, H1 2015 18

Number of Products under Development by Companies, H1 2015 (Contd..1) 19

Number of Products under Development by Companies, H1 2015 (Contd..2) 20

Number of Products under Investigation by Universities/Institutes, H1 2015 21

Comparative Analysis by Late Stage Development, H1 2015 22

Comparative Analysis by Clinical Stage Development, H1 2015 23

Comparative Analysis by Early Stage Development, H1 2015 24

Products under Development by Companies, H1 2015 25

Products under Development by Companies, H1 2015 (Contd..1) 26

Products under Development by Companies, H1 2015 (Contd..2) 27

Products under Development by Companies, H1 2015 (Contd..3) 28

Products under Investigation by Universities/Institutes, H1 2015 29

Mantle Cell Lymphoma-Pipeline by AbbVie Inc., H1 2015 30

Mantle Cell Lymphoma-Pipeline by Accentia Biopharmaceuticals, Inc., H1 2015 31

Mantle Cell Lymphoma-Pipeline by Actinium Pharmaceuticals, Inc., H1 2015 32

Mantle Cell Lymphoma-Pipeline by Advancell, H1 2015 33

Mantle Cell Lymphoma-Pipeline by Affimed Therapeutics AG, H1 2015 34

Mantle Cell Lymphoma-Pipeline by Amgen Inc., H1 2015 35

Mantle Cell Lymphoma-Pipeline by Astellas Pharma Inc., H1 2015 36

Mantle Cell Lymphoma-Pipeline by Astex Pharmaceuticals, Inc., H1 2015 37

Mantle Cell Lymphoma-Pipeline by Bayer AG, H1 2015 38

Mantle Cell Lymphoma-Pipeline by Bristol-Myers Squibb Company, H1 2015 39

Mantle Cell Lymphoma-Pipeline by Celgene Corporation, H1 2015 40

Mantle Cell Lymphoma-Pipeline by Celldex Therapeutics, Inc., H1 2015 41

Mantle Cell Lymphoma-Pipeline by Eisai Co., Ltd., H1 2015 42

Mantle Cell Lymphoma-Pipeline by Eli Lilly and Company, H1 2015 43

Mantle Cell Lymphoma-Pipeline by EpiZyme, Inc., H1 2015 44

Mantle Cell Lymphoma-Pipeline by Gilead Sciences, Inc., H1 2015 45

Mantle Cell Lymphoma-Pipeline by GlaxoSmithKline plc, H1 2015 46

Mantle Cell Lymphoma-Pipeline by ImmunoGen, Inc., H1 2015 47

Mantle Cell Lymphoma-Pipeline by Incyte Corporation, H1 2015 48

Mantle Cell Lymphoma-Pipeline by Infinity Pharmaceuticals, Inc., H1 2015 49

Mantle Cell Lymphoma-Pipeline by Johnson & Johnson, H1 2015 50

Mantle Cell Lymphoma-Pipeline by Karyopharm Therapeutics, Inc., H1 2015 51

Mantle Cell Lymphoma-Pipeline by Kite Pharma, Inc., H1 2015 52

Mantle Cell Lymphoma-Pipeline by MedImmune, LLC, H1 2015 53

Mantle Cell Lymphoma-Pipeline by Merck & Co., Inc., H1 2015 54

Mantle Cell Lymphoma-Pipeline by Millennium Pharmaceuticals, Inc., H1 2015 55

Mantle Cell Lymphoma-Pipeline by MorphoSys AG, H1 2015 56

Mantle Cell Lymphoma-Pipeline by Nordic Nanovector AS, H1 2015 57

Mantle Cell Lymphoma-Pipeline by Novartis AG, H1 2015 58

Mantle Cell Lymphoma-Pipeline by Onconova Therapeutics, Inc., H1 2015 59

Mantle Cell Lymphoma-Pipeline by Onyx Pharmaceuticals, Inc., H1 2015 60

Mantle Cell Lymphoma-Pipeline by Pfizer Inc., H1 2015 61

Mantle Cell Lymphoma-Pipeline by Pharmacyclics, Inc., H1 2015 62

Mantle Cell Lymphoma-Pipeline by Portola Pharmaceuticals, Inc., H1 2015 63

Mantle Cell Lymphoma-Pipeline by Seattle Genetics, Inc., H1 2015 64

Mantle Cell Lymphoma-Pipeline by Sevion Therapeutics, Inc., H1 2015 65

Mantle Cell Lymphoma-Pipeline by Stemline Therapeutics, Inc., H1 2015 66

Mantle Cell Lymphoma-Pipeline by Teva Pharmaceutical Industries Limited, H1 2015 67

Mantle Cell Lymphoma-Pipeline by TG Therapeutics, Inc., H1 2015 68

Assessment by Monotherapy Products, H1 2015 69

Assessment by Combination Products, H1 2015 70

Number of Products by Stage and Target, H1 2015 72

Number of Products by Stage and Mechanism of Action, H1 2015 75

Number of Products by Stage and Route of Administration, H1 2015 78

Number of Products by Stage and Molecule Type, H1 2015 80

Mantle Cell Lymphoma Therapeutics-Recent Pipeline Updates, H1 2015 214

Mantle Cell Lymphoma-Dormant Projects, H1 2015 319

Mantle Cell Lymphoma-Dormant Projects (Contd..1), H1 2015 320

Mantle Cell Lymphoma-Discontinued Products, H1 2015 321



Purchase Complete Report at http://www.reportsweb.com/buy&RW0001172452/buy/2000



ReportsWeb.com

Priya Sisodia

+1-646-491-9876

sales@reportsweb.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC